The test — developed by researchers at University of Pennsylvania’s Perelman School of Medicine, Abramson Cancer Center and School of Engineering and Applied Science — could play a valuable role in guiding treatment of the most common form of pancreatic cancer. If detected early, curative-intent surgery is possible. Read more . . .
A liquid biopsy has shown promise for the early detection and staging of pancreatic ductal adenocarcinoma.